The Conversation (0)
Epicore BioNetworks released the financial results for the third quarter of their fiscal year 2017.
Epicore BioNetworks (TSXV:EBN) released the financial results for the third quarter of their fiscal year 2017.
As quoted in the press release:
Epicore BioNetworks reported third quarter revenue of $3.0 million and net income of $0.4 million or $0.015 per share for the period ended March 31, 2017.
Third quarter revenue was 3% higher than last year’s Q3. Revenue for the first nine months at $8.5 million was 18% higher than last year. Net income was $0.4 million in Q3, a decrease of $0.3 million or 41% less than prior year Q3. Q3 earnings before interest, tax, and depreciation (EBITDA) were $1.0 million or 7% above prior year. Taxes increased by $0.3 million over prior year Q3 because of a reduction in tax provision estimated earlier in the year in anticipation of completing a new building in NJ. The building start is delayed so the tax depreciation will move to fiscal 2018. Sales grew in most business sectors with the largest increase in Latin America.
Click here to read the full press release.
Source: www.newswire.ca